The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Recurrence and Tailoring Radiotherapy Following Neoadjuvant Chemotherapy

Eleftherios Mamounas, MD, MPH
Published Online: 6:08 PM, Thu September 4, 2014
Eleftherios Mamounas, MD, MPH, medical director, Comprehensive Breast Program, University of Florida Health Cancer Center, discusses locoregional recurrence and tailoring radiotherapy following neoadjuvant chemotherapy.

Clinical Pearls

  • Researchers are trying to understand whether the response and tumor subtype of patients treated with neoadjuvant chemotherapy can help to tailor the use of radiotherapy afterwards.
  • Though the data from this analysis do not provide a definitive answer, they help researchers understand that these patients had low rates of recurrence and tailoring radiotherapy is possible. Trials are in progress to test this concept.

<<< Back to the 2014 Breast Cancer Symposium conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.